Intellectual Property India Publishes Patent Application for 'Nucleotide Analog, And Composition And Use Thereof' Filed by Shenzhen Targetrx, Inc.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517056221 A) filed by Shenzhen Targetrx, Inc., Guangdong, China, on June 11, for 'nucleotide analog, and composition and use thereof.'

Inventor(s) include Wang, Yihan; and Zhao, Jiuyang.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a compound of formula (I) or a tautomer, a stereoisomer, a prodrug, a crystalline form, a pharmaceutically acceptable salt, a hydrate or a solvate thereof, a pharmaceutical composition thereof, and use of these substances in the treatment and/or prevention of viral infections."

The patent application was internationally filed on Dec. 07, 2023, under International application No.PCT/CN2023/136943.

Disclaimer: Curated by HT Syndication.